US 9228002
Leishmania vaccine using sand fly salivary immunogen
granted A61KA61K2039/53A61K2039/58
Quick answer
US patent 9228002 (Leishmania vaccine using sand fly salivary immunogen) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/53, A61K2039/58, A61K39/00, A61K39/0003